Flovent

DRUG2 trials

Sponsors

University of British Columbia, Marc Rothenberg, MD

Conditions

Chronic Obstructive Pulmonary DiseaseEosinophilic Esophagitis

Phase 2

A Study of Flovent in Patients With Eosinophilic Esophagitis

CompletedNCT00426283

Marc Rothenberg, MDEosinophilic Esophagitis

Start: 2007-01-31End: 2012-03-31Updated: 2020-10-19

Phase 4

Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial

University of British ColumbiaChronic Obstructive Pulmonary Disease

Start: 2004-12-31End: 2006-08-31Target: 250Updated: 2006-05-09

Related Papers

Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis.

2014-04-22177 citations